sues with HCC. In noncancerous tissues of livers with Many studies concerning g-glutamyl transpeptidase HCC, the main types were types A and B. The prevalence (GGTP) in hepatocellular carcinoma (HCC) have sugof type B was significantly higher in both cancerous and gested that changes in hepatic GGTP
Screening of arylboronic acids to search for a strong inhibitor for γ-glutamyl transpeptidase (γ-GTP)
✍ Scribed by Hikaru Suenaga; Kazuaki Nakashima; Masafumi Mikami; Hiromasa Yamamoto; Tony D. James; K. R. A. Samankumara Sandanayake; Seiji Shinkai
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 453 KB
- Volume
- 115
- Category
- Article
- ISSN
- 0165-0513
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
In a study of the development of a strong inhibitor for γ‐glutamyl transpeptidase (γ‐GTP), the inhibitory effect of 21 arylboronic acids was determined in the γ‐GTP‐mediated hydrolysis of N‐(L‐γ‐glutamyl)‐4‐nitroanilide. It was shown that most boronic acids can moderately inhibit the enzyme activity and, in particular, the inhibitory effects of (3‐formylphenyl)boronic acid and (3‐carboxyphenyl)boronic acid (9% and 12%, respectively) are comparable to that reported for the binary L‐serine‐plus‐borate inhibition system (7%). Furthermore, it was shown that the addition of physiologically nontoxic saccharides is very effective in regenerating the enzyme activity. This effect is attributed to the competitive binding of saccharides with the boronic acid inhibitor to pull it out into the water phase. Thus, this paper offers a novel methodology for inhibition and control of γ‐GTP activity.
📜 SIMILAR VOLUMES
## Abstract The diastereoselective synthesis of the sterically hindered, __γ__‐branched __α__‐amino acid derivative (2__S__,4__S__)‐**24a** and its __N__‐[(__tert__‐butoxy)carbonyl](Boc)‐protected alcohol (2__S__,4__S__)‐**19**, both key intermediates of a novel class of nonpeptide renin inhibitors